Juvenile idiopathic arthritis

Pediatrics in Review

Volumn 33, Issue 7, 2012, Pages 303-313

  Espinosa, Maria ^a   Gottlieb, Beth S ^a  

^a Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISTREPTOLYSIN; AZATHIOPRINE; C REACTIVE PROTEIN; CELECOXIB; CORTICOSTEROID; CYCLOSPORIN; GLUCOCORTICOID; HLA B27 ANTIGEN; HLA DRB1 ANTIGEN; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; INTERLEUKIN 6; LEFLUNOMIDE; LIVER ENZYME; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ACNE; ADRENAL SUPPRESSION; ANEMIA; APPETITE; ARTHRITIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; AVASCULAR NECROSIS; BLOOD CLOTTING DISORDER; CATARACT; COMPARATIVE STUDY; CONJUNCTIVITIS; CUSHINGOID SYNDROME; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE DURATION; ENTHESITIS; ENVIRONMENTAL FACTOR; ERYTHROCYTE SEDIMENTATION RATE; FEVER; GASTROINTESTINAL INFECTION; GROWTH DISORDER; HEART DISEASE; HEMATOLOGIC DISEASE; HEPATOSPLENOMEGALY; HEREDITY; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY DISEASE; LEUKOCYTOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LOW DRUG DOSE; MACROPHAGE ACTIVATION SYNDROME; MOOD CHANGE; MOUTH ULCER; NEUROLOGIC DISEASE; OCCUPATIONAL THERAPY; OLIGOARTICULAR ARTHRITIS; OSTEOPENIA; OSTEOPOROSIS; PANCYTOPENIA; PATHOPHYSIOLOGY; PHYSIOTHERAPY; POLYARTHRITIS; PORPHYRIA CUTANEA TARDA; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC FEVER; SIDE EFFECT; T LYMPHOCYTE; THROMBOCYTOSIS; TREATMENT OUTCOME; UNITED STATES; URETHRITIS; UROGENITAL TRACT INFECTION; WEIGHT GAIN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, PSORIATIC; CHILD; HUMANS; IRITIS; PATIENT CARE TEAM; PROGNOSIS; STEM CELL TRANSPLANTATION;

EID: 84863552263     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.33-7-303     Document Type: Review

References (9)

1. Weiss JE, Ilowite NT. Juvenile idiopathic arthritis. Rheum Dis Clin North Am. 2007;33(3):441-470, vi (Pubitemid 47532351)
2. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767-778
3. Rabinovich CE. Juvenile rheumatoid arthritis. Emedicine. Available at: http://emedicine.medscape.com/article/1007276. Accessed October 6, 2011
4. Woo P, Colbert RA. An overview of genetics of paediatric rheumatic diseases. Best Pract Res Clin Rheumatol. 2009;23(5):589-597
5. Prakken BJ, Albani S. Using biology of disease to understand and guide therapy of JIA. Best Pract Res Clin Rheumatol. 2009;23(5):599-608
6. Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of Pediatric Rheumatology. 5th ed. Philadelphia, PA: Elsevier Inc.; 2005
7. McCann LJ, Wedderburn LR, Hassan N. Juvenile idiopathic arthritis. Arch Dis Child Educ Pract Ed. 2006;91:ep29-ep36 (Pubitemid 44197164)
8. Quartier P. Current treatments for juvenile idiopathic arthritis. Joint Bone Spine. 2010;77(6):511-516
9. Foeldvari I, Nielsen S, Kümmerle-Deschner J, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol. 2007;34(5):1146-1150 (Pubitemid 46774863)